Trametinib
Trametinib
To Order Contact us: caitlyn@ucb-bioproducts.com
Trametinib (GSK1120212) |
|||
| A3018-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
|||
Trametinib (DMSO solvate) |
|||
| HY-10999A | MedChemExpress | 100mg | EUR 214 |
Trametinib DMSO solvate |
|||
| A3887-10 | ApexBio | 10 mg | EUR 108 |
|
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
|||
Trametinib DMSO solvate |
|||
| A3887-100 | ApexBio | 100 mg | EUR 187 |
|
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
|||
Trametinib DMSO solvate |
|||
| A3887-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
|
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
|||
Trametinib DMSO solvate |
|||
| A3887-50 | ApexBio | 50 mg | EUR 142 |
|
Description: Trametinib (also known as GSK1120212 or JTP 74057), originally identified as a p15 inductive compound, is a novel and potent allosteric inhibitor of MEK kinase, which exhibits ATP non-competitive inhibition against MEK1 and MEK2 kinase. |
|||